Notice to Extend the Expiration Date for PAR-25-096 "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trial Not Allowed)"

Published on May 28, 2026

Notice NOT-CA-26-012 from the NIH Guide for Grants and Contracts

Continue reading on website
Other news

Notice to Extend the Expiration Date for PAR-25-095 "Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)"

May 28, 2026
Notice NOT-CA-26-011 from the NIH Guide for Grants and Contracts

Botulinum toxin type A for subacute/chronic neck pain

May 29, 2026
Cochrane Database Syst Rev. 2026 May 28;5:CD008626. doi: 10.1002/14651858.CD008626.pub4.ABSTRACTRATIONALE: Botulinum toxin type A (BoNT-A) intramuscular injections are commonly administered for neck pain unresponsive to other therapies, but the benefit-harm profile remains uncertain.OBJECTIVES: To assess the benefits and harms of intramuscular BoNT-A injection for people with subacute to chronic n